Flumetasone + Salicylic acid

Generic Medicine Info
Indications and Dosage
Inflammatory and/or dysplastic skin diseases
Adult: Each g of ointment contains flumetasone pivalate 0.02% and salicylic acid 3%. Apply a thin layer onto the affected areas 1-2 times daily. To be applied only once daily if occlusive dressing is used.
Systemic fungal infections, untreated bacterial infections. Tuberculosis of skin, syphilitic skin infections, viral and acute fungal infections of the skin, acne vulgaris, perioral dermatitis, rosacea.
Special Precautions
Not to be used on acute weeping or subacute exudative wounds. Severe renal impairment. Avoid repeated application to large extensive skin areas as substantial absorption of the drugs may lead to systemic effects. Monitor adrenal function in patients requiring extensive application and/or application under occlusive dressings. Avoid use on eyes, mouth and mucous membranes. Risk of secondary infection during the use of topical corticosteroids. Discontinue treatment if there is atrophy of skin and/or subcutaneous tissues. Patients with stasis dermatitis or skin diseases associated with impaired blood curculation. Caution when used in infants and children. Pregnancy and lactation.
Adverse Reactions
Local erythema, dryness, pruritus, smarting and desquamation. Change in pigmentation, secondary infections and contact allergy. When occlusive dressings are used, miliaria, pustules, folliculitis and pyoderma may occur.
Mechanism of Action: Flumetasone is a corticosteroid that is used topically for the treatment of various skin disorders. It has anti-inflammatory, antipruritic and antiallergic properties. Salicylic acid is squamolytic and mildly keratolytic, thus aiding transepidermal penetration of the active ingredients. It also has some antiseptic effect against bacteria and fungi.
MIMS Class
Psoriasis, Seborrhea & Ichthyosis Preparations
Disclaimer: This information is independently developed by MIMS based on Flumetasone + Salicylic acid from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in